- Home
- IOVA vs VERB Comparison
IOVA vs VERB Comparison
Compare IOVA & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- VERB
- Stock Information
- Founded
- IOVA 2007
- VERB 2014
- Country
- IOVA United States
- VERB United States
- Employees
- IOVA N/A
- VERB 23
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- VERB Other Consumer Services
- Sector
- IOVA Health Care
- VERB Consumer Discretionary
- Exchange
- IOVA Nasdaq
- VERB Nasdaq
- Market Cap
- IOVA 975.1M
- VERB 877.8M
- IPO Year
- IOVA N/A
- VERB N/A
- Fundamental
- Price
- IOVA $2.38
- VERB $7.98
- Analyst Decision
- IOVA Buy
- VERB Strong Buy
- Analyst Count
- IOVA 11
- VERB 1
- Target Price
- IOVA $11.90
- VERB $62.00
- AVG Volume (30 Days)
- IOVA 11.2M
- VERB 2.1M
- Earning Date
- IOVA 11-06-2025
- VERB 08-06-2025
- Dividend Yield
- IOVA N/A
- VERB N/A
- EPS Growth
- IOVA N/A
- VERB N/A
- EPS
- IOVA N/A
- VERB N/A
- Revenue
- IOVA $241,525,000.00
- VERB $4,279,000.00
- Revenue This Year
- IOVA $67.40
- VERB $526.82
- Revenue Next Year
- IOVA $56.32
- VERB $45.45
- P/E Ratio
- IOVA N/A
- VERB N/A
- Revenue Growth
- IOVA 636.99
- VERB 4095.10
- 52 Week Low
- IOVA $1.64
- VERB $3.81
- 52 Week High
- IOVA $12.51
- VERB $29.77
- Technical
- Relative Strength Index (RSI)
- IOVA 49.08
- VERB 30.59
- Support Level
- IOVA $2.27
- VERB $9.58
- Resistance Level
- IOVA $2.46
- VERB $21.78
- Average True Range (ATR)
- IOVA 0.14
- VERB 1.61
- MACD
- IOVA 0.00
- VERB -1.27
- Stochastic Oscillator
- IOVA 49.09
- VERB 0.93
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.